Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-08-01-2009
Volume0
Issue 0

Applied Clinical Trials Digital Edition - August 2009

EDC : Getting it Right - EDC Rescue Studies INFORMATION TECHNOLOGY : How Health Intelligence Leads to Smarter Research CRO/SPONSOR : The Proactive Advantage in Risk Management Also in this issue : All Eyes on R&D as U.S. Talks Health Care, Fragmented System Stifling EU Research, IT Convergence: Are We There Yet?, Why Virtual Meetings Make Sense

External Link - article-821292.pdf

Articles in this issue
Applied Clinical Trials Digital Edition - August 2009
i1-617466-1408646341258.jpg
eClinical Software: August 2009
i1-617470-1408646321736.jpg
Welcome to the Age of Convergence
i1-617460-1408646366096.jpg
Health Reform Shapes Drug Development
i1-617462-1408646356623.jpg
From EDC Emerges eClinical
i1-617461-1408646360126.jpg
WHO Boosts Research in Africa

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Biogen, Stoke Therapeutics Launch Phase III Trial of Investigational Antisense Therapy for Dravet Syndrome
August 12th 2025

Biogen, Stoke Therapeutics Launch Phase III Trial of Investigational Antisense Therapy for Dravet Syndrome

Don Tracy, Associate Editor
ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials
August 12th 2025

ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials

Andy Studna, Senior Editor
Genmab’s Epkinly Shows Major Survival Benefit in Relapsed, Refractory Follicular Lymphoma
August 12th 2025

Genmab’s Epkinly Shows Major Survival Benefit in Relapsed, Refractory Follicular Lymphoma

Don Tracy, Associate Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 12th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss
August 12th 2025

Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss

Don Tracy, Associate Editor
© Satjawat - © Satjawat - stock.adobe.com
August 12th 2025

Tegoprazan Shows Superior Maintenance of Healing in Phase III TRIUMpH Study of Gastroesophageal Reflux Disease

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.